164 related articles for article (PubMed ID: 28487222)
1. Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence.
Tikhonova MA; Ho SC; Akopyan AA; Kolosova NG; Weng JC; Meng WY; Lin CL; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2017 Jul; 330():8-16. PubMed ID: 28487222
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson's disease dementia.
Hsieh MH; Meng WY; Liao WC; Weng JC; Li HH; Su HL; Lin CL; Hung CS; Ho YJ
Brain Res Bull; 2017 Jun; 132():129-138. PubMed ID: 28576659
[TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson's disease rat model: An immunohistochemical and MRI study.
Weng JC; Tikhonova MA; Chen JH; Shen MS; Meng WY; Chang YT; Chen KH; Liang KC; Hung CS; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2016 May; 305():126-39. PubMed ID: 26940602
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of ceftriaxone and erythropoietin on neuronal and behavioral deficits in an MPTP-induced animal model of Parkinson's disease dementia.
Huang CK; Chang YT; Amstislavskaya TG; Tikhonova MA; Lin CL; Hung CS; Lai TJ; Ho YJ
Behav Brain Res; 2015 Nov; 294():198-207. PubMed ID: 26296668
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties.
Tikhonova MA; Amstislavskaya TG; Belichenko VM; Fedoseeva LA; Kovalenko SP; Pisareva EE; Avdeeva AS; Kolosova NG; Belyaev ND; Aftanas LI
BMC Neurosci; 2018 Apr; 19(Suppl 1):13. PubMed ID: 29745864
[TBL] [Abstract][Full Text] [Related]
6. Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model.
Ho SC; Hsu CC; Pawlak CR; Tikhonova MA; Lai TJ; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2014 Jul; 268():177-84. PubMed ID: 24755306
[TBL] [Abstract][Full Text] [Related]
7. Neurodevelopment and behavior in neonatal OXYS rats with genetically determined accelerated senescence.
Igonina TN; Ragaeva DS; Tikhonova MA; Petrova OM; Herbeck YE; Rozhkova IN; Amstislavskaya TG; Amstislavsky SY
Brain Res; 2018 Feb; 1681():75-84. PubMed ID: 29274882
[TBL] [Abstract][Full Text] [Related]
8. Use of Ceftriaxone in Treating Cognitive and Neuronal Deficits Associated With Dementia With Lewy Bodies.
Ho YJ; Shen MS; Tai CH; Li HH; Chen JH; Liao WC; Chiu PY; Lee IY; Lin CL; Hung CS
Front Neurosci; 2019; 13():507. PubMed ID: 31178684
[TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia.
Hsu CY; Hung CS; Chang HM; Liao WC; Ho SC; Ho YJ
Neuropharmacology; 2015 Apr; 91():43-56. PubMed ID: 25499022
[TBL] [Abstract][Full Text] [Related]
10. Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer's type.
Bassani TB; Turnes JM; Moura ELR; Bonato JM; Cóppola-Segovia V; Zanata SM; Oliveira RMMW; Vital MABF
Behav Brain Res; 2017 Sep; 335():41-54. PubMed ID: 28801114
[TBL] [Abstract][Full Text] [Related]
11. Treatment effects of the combination of ceftriaxone and valproic acid on neuronal and behavioural functions in a rat model of epilepsy.
Li HH; Lin PJ; Wang WH; Tseng LH; Tung H; Liu WY; Lin CL; Liu CH; Liao WC; Hung CS; Ho YJ
Exp Physiol; 2021 Aug; 106(8):1814-1828. PubMed ID: 34086374
[TBL] [Abstract][Full Text] [Related]
12. [MORPHOLOGICAL CHARACTERIZATION OF OXYS AND WISTAR RAT HIPPOCAMPUS IN THE AGING PROCESS].
Maksimova KY; Logvinov SV; Stefanova NA
Morfologiia; 2015; 147(3):11-6. PubMed ID: 26390540
[TBL] [Abstract][Full Text] [Related]
13. Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats.
Kolosova NG; Shcheglova TV; Sergeeva SV; Loskutova LV
Neurobiol Aging; 2006 Sep; 27(9):1289-97. PubMed ID: 16246464
[TBL] [Abstract][Full Text] [Related]
14. Influence of Antioxidant SkQ1 on Accumulation of Mitochondrial DNA Deletions in the Hippocampus of Senescence-Accelerated OXYS Rats.
Loshchenova PS; Sinitsyna OI; Fedoseeva LA; Stefanova NA; Kolosova NG
Biochemistry (Mosc); 2015 May; 80(5):596-603. PubMed ID: 26071779
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol prevents akinesia and restores neuronal tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta of diabetic rats.
Brambilla Bagatini P; Xavier LL; Neves L; Saur L; Barbosa S; Baptista PP; Augustin OA; Nunes de Senna P; Mestriner RG; Souto AA; Achaval M
Brain Res; 2014 Dec; 1592():101-12. PubMed ID: 25446006
[TBL] [Abstract][Full Text] [Related]
16. Comparison of behavioral and biochemical deficits in rats with hereditary defined or D-galactose-induced accelerated senescence: evaluating the protective effects of diosgenin.
Tikhonova MA; Yu CH; Kolosova NG; Gerlinskaya LA; Maslennikova SO; Yudina AV; Amstislavskaya TG; Ho YJ
Pharmacol Biochem Behav; 2014 May; 120():7-16. PubMed ID: 24495488
[TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K/Akt/NF-κB signaling pathway.
Feng D; Wang W; Dong Y; Wu L; Huang J; Ma Y; Zhang Z; Wu S; Gao G; Qin H
Neuroscience; 2014 May; 268():21-32. PubMed ID: 24631672
[TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats.
Bisht R; Kaur B; Gupta H; Prakash A
Neurotoxicology; 2014 Sep; 44():71-9. PubMed ID: 25053526
[TBL] [Abstract][Full Text] [Related]
19. Ceftriaxone Treatment for Neuronal Deficits: A Histological and MEMRI Study in a Rat Model of Dementia with Lewy Bodies.
Ho YJ; Weng JC; Lin CL; Shen MS; Li HH; Liao WC; Tsai NM; Hung CS; Lai TJ; Lee IY
Behav Neurol; 2018; 2018():4618716. PubMed ID: 30154934
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.
Stefanova NA; Muraleva NA; Skulachev VP; Kolosova NG
J Alzheimers Dis; 2014; 38(3):681-94. PubMed ID: 24047616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
